by jtcir-auto | Feb 21, 2020 | Press Releases
CHARLESTON, S.C., Feb. 21, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests,...
by jtcir-auto | Feb 21, 2020 | Press Releases
CHARLESTON, S.C., Feb. 21, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests,...
by jtcir-auto | Feb 20, 2020 | Press Releases
CHARLESTON, S.C., Feb. 19, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests,...
by jtcir-auto | Feb 20, 2020 | Press Releases
CHARLESTON, S.C., Feb. 19, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests,...
by jtcir-auto | Feb 12, 2020 | Press Releases
Presentation on Monday, February 17th at 11:30 a.m. ETCHARLESTON, S.C., Feb. 12, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), specialty biopharmaceutical company commercializing...